0

Close
 
Upcoming Allied Market Research
2023
Cardiovascular Surgical Devices And Technologies Market

Cardiovascular Surgical Devices and Technologies Market

by SURGICAL DEVICES (Beating Heart Surgery Systems, Perfusion Disposables, CPB Equipment, Cardiac Ablation Devices) and by CARDIAC RHYTHM MANAGEMENT DEVICES (Arrhythmias, Atrial Fibrillation, Pacemakers, Defibrillators, Electrophysiology Catheters): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A00106
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Cardiovascular Surgical Devices And Technologies Market

Request Now !

Cardiovascular surgery is the process performed to cure the heart tissue defects such as replacing the diseased heart valves if it is blocked, grafting or replacement of heart tissues in case of damage. There are two major types of heart surgeries performed, namely closed and open types of surgeries. The global surgical device market is the parent market for cardiovascular devices, which was valued at $240 billion in 2013. Increase in incidence for heart related problems are mainly due to changes in life style. This life style changes has increased the rate of heart surgeries. The U.S. is the leading market for cardiovascular surgical devices due to increase in aging population that is suffering from cardiovascular problems.

The growth of cardiovascular surgical devices market was hampered by efficient alternative technologies such as percutaneous coronary intervention (PCI) techniques and other minimal invasive techniques (Ablation techniques); moreover, shortage of skilled surgeons and high cost of surgical procedures are hindering the growth of cardiovascular surgical device market in developing countries. Lower success rate of heart related surgeries in minimal invasive techniques is reducing the growth of cardiovascular surgical device market in developing economies.

The global cardiovascular surgical device market is dominated by established companies due to high cost of investment require for breaking surgical device market. Cardiovascular surgical device market is facing challenges from alternative technologies that are developing at a faster rate as compared to surgical technologies. However, lower success rate of these alternative technologies has reduced the growth in cardiovascular surgical market in developing countries. This report provides market intelligence of revenue and growth rate during analysis period. The report also provides key developmental strategies adopted by top companies engaged in surgical device manufacturing. The report provides market intelligence on current trends and future transition of surgical devices.

Key companies included in company profiles are Abbott Cardiovascular, Abiomed, Inc., Boston Scientific Corp., C.R. Bard, INC., St. Jude Medical, Thoratec Laboratories, Transmedics, Inc., Cook Medical, Cordis Corp., and Angiodynamics, Inc.

KEY BENEFITS

  • The market estimation made in this report by collecting primary information from respective companies involved in manufacturing of medical devices. Analyzing secondary information provides competitive analysis about trends 
  • The report analyzes the key developmental strategies adopted by top ranking companies and change in trends for this adoption
  • Practical evaluation of key market drivers and restraints
  • This report provides emphasis on key factors impacting the growth of portable medical device market
  • Patent analysis for different geographic regions is dealt with key clinical trials and applications

 Cardiovascular Surgical Devices and Technologies Market Report Highlights

Aspects Details
By SURGICAL DEVICES
  • Beating Heart Surgery Systems
  • Perfusion Disposables
  • CPB Equipment
  • Cardiac Ablation Devices
By CARDIAC RHYTHM MANAGEMENT DEVICES
  • Arrhythmias
  • Atrial Fibrillation
  • Pacemakers
  • Defibrillators
  • Electrophysiology Catheters
By GEOGRAPHY
  • North America
  • Europe
  • Asia-Pacific
  • RoW
Key Market Players Academic And Medical Institutes, Medical Device Manufacturing Companies, Pharmaceutical Companies, Research Institutes
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET, BY SURGICAL DEVICES

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Surgical Devices

    • 4.2. Beating Heart Surgery Systems

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Perfusion Disposables

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. CPB Equipment

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Cardiac Ablation Devices

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Cardiac Rhythm Management Devices

    • 5.2. Arrhythmias

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Atrial Fibrillation

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Pacemakers

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Defibrillators

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Electrophysiology Catheters

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

  • CHAPTER 6: CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Surgical Devices

      • 6.2.3. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Cardiovascular Surgical Devices And Technologies Market

        • 6.2.5.1. Market Size and Forecast, By Surgical Devices
        • 6.2.5.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.2.6. Canada Cardiovascular Surgical Devices And Technologies Market

        • 6.2.6.1. Market Size and Forecast, By Surgical Devices
        • 6.2.6.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.2.7. Mexico Cardiovascular Surgical Devices And Technologies Market

        • 6.2.7.1. Market Size and Forecast, By Surgical Devices
        • 6.2.7.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Surgical Devices

      • 6.3.3. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Cardiovascular Surgical Devices And Technologies Market

        • 6.3.5.1. Market Size and Forecast, By Surgical Devices
        • 6.3.5.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.3.6. Germany Cardiovascular Surgical Devices And Technologies Market

        • 6.3.6.1. Market Size and Forecast, By Surgical Devices
        • 6.3.6.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.3.7. Italy Cardiovascular Surgical Devices And Technologies Market

        • 6.3.7.1. Market Size and Forecast, By Surgical Devices
        • 6.3.7.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.3.8. Spain Cardiovascular Surgical Devices And Technologies Market

        • 6.3.8.1. Market Size and Forecast, By Surgical Devices
        • 6.3.8.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.3.9. UK Cardiovascular Surgical Devices And Technologies Market

        • 6.3.9.1. Market Size and Forecast, By Surgical Devices
        • 6.3.9.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.3.10. Russia Cardiovascular Surgical Devices And Technologies Market

        • 6.3.10.1. Market Size and Forecast, By Surgical Devices
        • 6.3.10.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.3.11. Rest Of Europe Cardiovascular Surgical Devices And Technologies Market

        • 6.3.11.1. Market Size and Forecast, By Surgical Devices
        • 6.3.11.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Surgical Devices

      • 6.4.3. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Cardiovascular Surgical Devices And Technologies Market

        • 6.4.5.1. Market Size and Forecast, By Surgical Devices
        • 6.4.5.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.4.6. Japan Cardiovascular Surgical Devices And Technologies Market

        • 6.4.6.1. Market Size and Forecast, By Surgical Devices
        • 6.4.6.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.4.7. India Cardiovascular Surgical Devices And Technologies Market

        • 6.4.7.1. Market Size and Forecast, By Surgical Devices
        • 6.4.7.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.4.8. South Korea Cardiovascular Surgical Devices And Technologies Market

        • 6.4.8.1. Market Size and Forecast, By Surgical Devices
        • 6.4.8.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.4.9. Australia Cardiovascular Surgical Devices And Technologies Market

        • 6.4.9.1. Market Size and Forecast, By Surgical Devices
        • 6.4.9.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.4.10. Thailand Cardiovascular Surgical Devices And Technologies Market

        • 6.4.10.1. Market Size and Forecast, By Surgical Devices
        • 6.4.10.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.4.11. Malaysia Cardiovascular Surgical Devices And Technologies Market

        • 6.4.11.1. Market Size and Forecast, By Surgical Devices
        • 6.4.11.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.4.12. Indonesia Cardiovascular Surgical Devices And Technologies Market

        • 6.4.12.1. Market Size and Forecast, By Surgical Devices
        • 6.4.12.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.4.13. Rest of Asia Pacific Cardiovascular Surgical Devices And Technologies Market

        • 6.4.13.1. Market Size and Forecast, By Surgical Devices
        • 6.4.13.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Surgical Devices

      • 6.5.3. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Cardiovascular Surgical Devices And Technologies Market

        • 6.5.5.1. Market Size and Forecast, By Surgical Devices
        • 6.5.5.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.5.6. South Africa Cardiovascular Surgical Devices And Technologies Market

        • 6.5.6.1. Market Size and Forecast, By Surgical Devices
        • 6.5.6.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.5.7. Saudi Arabia Cardiovascular Surgical Devices And Technologies Market

        • 6.5.7.1. Market Size and Forecast, By Surgical Devices
        • 6.5.7.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.5.8. UAE Cardiovascular Surgical Devices And Technologies Market

        • 6.5.8.1. Market Size and Forecast, By Surgical Devices
        • 6.5.8.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.5.9. Argentina Cardiovascular Surgical Devices And Technologies Market

        • 6.5.9.1. Market Size and Forecast, By Surgical Devices
        • 6.5.9.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

      • 6.5.10. Rest of LAMEA Cardiovascular Surgical Devices And Technologies Market

        • 6.5.10.1. Market Size and Forecast, By Surgical Devices
        • 6.5.10.2. Market Size and Forecast, By Cardiac Rhythm Management Devices

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Medical Device Manufacturing Companies

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Research Institutes

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Pharmaceutical Companies

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Academic And Medical Institutes

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR BEATING HEART SURGERY SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR PERFUSION DISPOSABLES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR CPB EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR CARDIAC ABLATION DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR ARRHYTHMIAS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR PACEMAKERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR DEFIBRILLATORS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR ELECTROPHYSIOLOGY CATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 16. U.S. CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 17. U.S. CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 18. CANADA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 19. CANADA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 20. MEXICO CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 21. MEXICO CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 22. EUROPE CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. EUROPE CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 24. EUROPE CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 25. FRANCE CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 26. FRANCE CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 27. GERMANY CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 28. GERMANY CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 29. ITALY CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 30. ITALY CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 31. SPAIN CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 32. SPAIN CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 33. UK CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 34. UK CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 35. RUSSIA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 36. RUSSIA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 37. REST OF EUROPE CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 38. REST OF EUROPE CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 39. ASIA-PACIFIC CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 40. ASIA-PACIFIC CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 41. ASIA-PACIFIC CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 42. CHINA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 43. CHINA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 44. JAPAN CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 45. JAPAN CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 46. INDIA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 47. INDIA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 48. SOUTH KOREA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 49. SOUTH KOREA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 50. AUSTRALIA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 51. AUSTRALIA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 52. THAILAND CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 53. THAILAND CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 54. MALAYSIA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 55. MALAYSIA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 56. INDONESIA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 57. INDONESIA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 58. REST OF ASIA PACIFIC CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 59. REST OF ASIA PACIFIC CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 60. LAMEA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 61. LAMEA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 62. LAMEA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 63. BRAZIL CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 64. BRAZIL CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH AFRICA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH AFRICA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 67. SAUDI ARABIA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 68. SAUDI ARABIA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 69. UAE CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 70. UAE CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 71. ARGENTINA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 72. ARGENTINA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 73. REST OF LAMEA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY SURGICAL DEVICES, 2022-2032 ($MILLION)
  • TABLE 74. REST OF LAMEA CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES, BY CARDIAC RHYTHM MANAGEMENT DEVICES, 2022-2032 ($MILLION)
  • TABLE 75. MEDICAL DEVICE MANUFACTURING COMPANIES: KEY EXECUTIVES
  • TABLE 76. MEDICAL DEVICE MANUFACTURING COMPANIES: COMPANY SNAPSHOT
  • TABLE 77. MEDICAL DEVICE MANUFACTURING COMPANIES: OPERATING SEGMENTS
  • TABLE 78. MEDICAL DEVICE MANUFACTURING COMPANIES: PRODUCT PORTFOLIO
  • TABLE 79. MEDICAL DEVICE MANUFACTURING COMPANIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 80. RESEARCH INSTITUTES: KEY EXECUTIVES
  • TABLE 81. RESEARCH INSTITUTES: COMPANY SNAPSHOT
  • TABLE 82. RESEARCH INSTITUTES: OPERATING SEGMENTS
  • TABLE 83. RESEARCH INSTITUTES: PRODUCT PORTFOLIO
  • TABLE 84. RESEARCH INSTITUTES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 85. PHARMACEUTICAL COMPANIES: KEY EXECUTIVES
  • TABLE 86. PHARMACEUTICAL COMPANIES: COMPANY SNAPSHOT
  • TABLE 87. PHARMACEUTICAL COMPANIES: OPERATING SEGMENTS
  • TABLE 88. PHARMACEUTICAL COMPANIES: PRODUCT PORTFOLIO
  • TABLE 89. PHARMACEUTICAL COMPANIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 90. ACADEMIC AND MEDICAL INSTITUTES: KEY EXECUTIVES
  • TABLE 91. ACADEMIC AND MEDICAL INSTITUTES: COMPANY SNAPSHOT
  • TABLE 92. ACADEMIC AND MEDICAL INSTITUTES: OPERATING SEGMENTS
  • TABLE 93. ACADEMIC AND MEDICAL INSTITUTES: PRODUCT PORTFOLIO
  • TABLE 94. ACADEMIC AND MEDICAL INSTITUTES: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET
  • FIGURE 3. SEGMENTATION CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET
  • FIGURE 11. CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET SEGMENTATION, BY BY SURGICAL DEVICES
  • FIGURE 12. CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR BEATING HEART SURGERY SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR PERFUSION DISPOSABLES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR CPB EQUIPMENT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR CARDIAC ABLATION DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET SEGMENTATION, BY BY CARDIAC RHYTHM MANAGEMENT DEVICES
  • FIGURE 17. CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR ARRHYTHMIAS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR PACEMAKERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR DEFIBRILLATORS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET FOR ELECTROPHYSIOLOGY CATHETERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 26. COMPETITIVE DASHBOARD
  • FIGURE 27. COMPETITIVE HEATMAP: CARDIOVASCULAR SURGICAL DEVICES AND TECHNOLOGIES MARKET
  • FIGURE 28. Top player positioning, 2022
  • FIGURE 29. MEDICAL DEVICE MANUFACTURING COMPANIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 30. MEDICAL DEVICE MANUFACTURING COMPANIES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 31. MEDICAL DEVICE MANUFACTURING COMPANIES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 32. RESEARCH INSTITUTES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 33. RESEARCH INSTITUTES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 34. RESEARCH INSTITUTES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 35. PHARMACEUTICAL COMPANIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 36. PHARMACEUTICAL COMPANIES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 37. PHARMACEUTICAL COMPANIES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 38. ACADEMIC AND MEDICAL INSTITUTES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. ACADEMIC AND MEDICAL INSTITUTES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. ACADEMIC AND MEDICAL INSTITUTES: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Cardiovascular Surgical Devices And Technologies Market

Start reading.
This Report and over 66,944+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers